Selected Filters

Filter Publications

About Publications

Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.

  • Released: July 24, 2002
    Use of dietary supplements has increased significantly over the past decade. While these products are presumed safe when used by consumers, the U.S. Food and Drug Administration (FDA) has no authority to require specific safety studies be done prior to the products' appearance on the market. Current laws require that FDA prove a supplement is unsafe in order to remove it from the marketplace. At the request of FDA, Food and Nutrition Board committee has proposed a scientifically based approach to be used by FDA for prioritizing and evaluating dietary supplement ingredients on the basis of available information on safety.
  • Released: July 19, 2002
    The workshop summary report explores the principles underlying the biological challenges, medical interventions, the continuing research agenda, and operational considerations for post-immunization strategies for vaccine-preventable viral diseases, and highlights important efforts that may facilitate wise decision making.
  • Released: June 10, 2002
    This report looked at the possibility that the scientific method could be accelerated to yield findings more quickly by identifying patterns of evolving evidence in nutrient-disease relationships.
  • Released: April 20, 2002
    To explore whether soccer playing puts youths at risk for lasting brain damage, the Institute of Medicine held a workshop on October 12, 2001 at which experts in head injury, sports medicine, pediatrics, and bioengineering were asked to explore the scope of the scientific evidence regarding head injuries in youth soccer.
  • Released: April 16, 2002
    Zoonotic diseases represent one of the leading causes of illness and death from infectious disease. Worldwide, zoonotic diseases have a negative impact on commerce, travel, and economies. In most developing countries, zoonotic diseases are among those diseases of major public health significance and contribute significantly to an already overly burdened public health system. The summary report of the workshop's presentations and discussions, The Emergence of Zoonotic Diseases: Understanding the Impact on Animal and Human Health, includes discussion summary and individually authored papers.
  • Released: January 29, 2002
    In a three-day workshop, convened by the Institute of Medicine's Forum on Emerging Infections, experts from each of these communities came together to identify, clarify, and prioritize the next steps that need to be taken in order to prepare and strengthen bioterrorism response capabilities.
  • Released: December 21, 2001
    On June 15, 2001 state and local health officials from Illinois, Michigan, and the cities of Chicago and Detroit met with representatives from federal health agencies, private health insurance plans, medical societies, and health centers to examine the implications of the findings and recommendations of the IOM report, Calling the Shots: Immunization Finance Policies and Practices ), for their jurisdictions.
  • Released: October 21, 2001
    The Committee on Military Nutrition Research of the Institute of Medicine's Food and Nutrition Board was asked by the U.S. Army Medical Research and Materiel Command (USAMRMC) to prepare a brief report that would assist the Department of Defense in transitioning civilian and military caffeine research to military application.
  • Released: June 01, 2001
  • Released: April 23, 2001
    The Centers for Disease Control and Prevention and the National Institutes of Health recognized the need for an independent group to carefully examine the hypothesized MMR-autism link and address other vaccine-safety issues as well, in order to give some guidance to themselves, health care providers, researchers, and a concerned public.

kamagra oral jelly 100mg